Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2025-09-04 2025-06-23
Drug Identification Number 02462699 02462699
Brand name ZEULIDE DEPOT ZEULIDE DEPOT
Common or Proper name Leuprolide Acetate Leuprolide Acetate
Company Name VERITY PHARMACEUTICALS INC. VERITY PHARMACEUTICALS INC.
Ingredients LEUPROLIDE ACETATE LEUPROLIDE ACETATE
Strength(s) 22.5MG 22.5MG
Dosage form(s) KIT POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size kit with one vial of drug and one syringe with adaptor kit with one vial of drug and one syringe with adaptor
ATC code L02AE L02AE
ATC description HORMONES AND RELATED AGENTS HORMONES AND RELATED AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2025-06-23 2025-06-23
Actual start date 2025-06-23 2025-06-23
Estimated end date 2025-08-08 2025-07-31
Actual end date 2025-08-08
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments